Ask a Fool: What's Your Foolish Opinion on Organovo?

In this video as part of The Motley Fool's "Ask a Fool" series, Fool health-care analyst David Williamson takes a question from a Fool reader, who writes, "What's your Foolish opinion on Organovo (NYSEMKT: ONVO  ) ? Buy, sell, or hold?"

David introduces investors to the company, which is working to develop the ability to use 3-D printing technology to create human livers, which would facilitate medical testing for liver toxicity without having to test on actual humans. David also warns that even though this is a potentially disruptive force, it's still so early in the development of its product that there's still a lot of risk for investors here, and he advises keeping this as no more than a tiny percentage of any investment portfolio.

Medical technology is changing so rapidly, how should investors pick winners?
The best way to play the biotech space is to find companies that shun the status quo and instead discover revolutionary, groundbreaking technologies. In The Motley Fool's brand-new free report "2 Game-Changing Biotechs Revolutionizing the Way We Treat Cancer," find out about a new technology that big pharma is endorsing through partnerships, and the two companies that are set to profit from this emerging drug class. Click here to get your copy today.

Read/Post Comments (3) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On February 11, 2014, at 1:48 PM, badeconomy wrote:


    State Street Corporation new BUY of 1,627,408 shares of onvo as of 12/31/2013

    Fidelity select portfolios new BUY of 1,753,017 shares of onvo as of 12/31/2013

    SPDR,S&P new BUY of 1,675,248 shares of onvo as of 1/31/2014

    Fidelity adviser fund new BUY of 244,983 shares of onvo as of 12/31/2013

    Vanguard Health fund new Buy of 63,120 shares of onvo as of 11/30/2013

  • Report this Comment On February 13, 2014, at 8:23 AM, judysway wrote:

    Dear David,

    My "foolish" opinion is that Organovo will outperform every stock there is out there! Why? They are the only company out there right now that is even attempting to do what we all hope they will do, make organs for transplant! The waiting room at my son's Doctors office is filled with young men in their 40's all waiting for new kidney's...why? Who knows, no common reasons! My son started dialysis last Monday, it is horrible and painful, he is 5th on the national transplant list. A young child (8years old) in Az is awaiting new lungs.. he is on life support as I write. Thousands are waiting to have life saving treatments. This company should be supported with all the money they can raise to hire more and more doctors and researchers until they accomplish what they hope to do...and that is to save lives. We can all try to live healthy lives, but, sooner or later, a loved one or we ourselves will get sick or injured. Support this company, you never know when you or a loved one will need the life saving tech they are striving for.

  • Report this Comment On February 24, 2014, at 6:37 PM, investisseuse wrote:

    My heart goes out to the father who wrote that letter. I hope with all that Organovo succeeds!

    If the shorts weren't in it so hard it would be easier to stick my neck out a little more with this wonderful stock. I do think he's right. Maybe we can all put a few dollars into such a life changing opportunity.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2833432, ~/Articles/ArticleHandler.aspx, 9/2/2015 12:33:39 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

David Williamson

The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...

Today's Market

updated 3 hours ago Sponsored by:
DOW 16,058.35 -469.68 -2.84%
S&P 500 1,913.85 -58.33 -2.96%
NASD 4,636.11 -140.40 -2.94%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/1/2015 4:00 PM
ONVO $2.45 Down -0.28 -10.26%